Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/165541
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorLukovic, Dunja-
dc.contributor.authorDíez-Lloret, Andrea-
dc.contributor.authorStojkovic, Petra-
dc.contributor.authorRodríguez Martínez, Daniel-
dc.contributor.authorRodríguez-Jiménez, Francisco Javier-
dc.contributor.authorGonzález-Rodríguez, Patricia-
dc.contributor.authorLópez-Barneo, José-
dc.contributor.authorMoreno-Manzano, Victoria-
dc.contributor.authorStojkovic, Miodrag-
dc.contributor.authorBhattacharya, Shom Shanker-
dc.contributor.authorErceg, Slaven-
dc.date.accessioned2018-06-01T13:07:32Z-
dc.date.available2018-06-01T13:07:32Z-
dc.date.issued2017-
dc.identifierdoi: 10.1002/sctm.16-0371-
dc.identifiere-issn: 2157-6580-
dc.identifierissn: 2157-6564-
dc.identifier.citationStem Cells 6(4): 1217-1226 (2017)-
dc.identifier.urihttp://hdl.handle.net/10261/165541-
dc.descriptionLukovic, Dunja et al.-
dc.description.abstractNeural differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can produce a valuable and robust source of human neural cell subtypes, holding great promise for the study of neurogenesis and development, and for treating neurological diseases. However, current hESCs and hiPSCs neural differentiation protocols require either animal factors or embryoid body formation, which decreases efficiency and yield, and strongly limits medical applications. Here we develop a simple, animal-free protocol for neural conversion of both hESCs and hiPSCs in adherent culture conditions. A simple medium formula including insulin induces the direct conversion of >98% of hESCs and hiPSCs into expandable, transplantable, and functional neural progenitors with neural rosette characteristics. Further differentiation of neural progenitors into dopaminergic and spinal motoneurons as well as astrocytes and oligodendrocytes indicates that these neural progenitors retain responsiveness to instructive cues revealing the robust applicability of the protocol in the treatment of different neurodegenerative diseases. The fact that this protocol includes animal-free medium and human extracellular matrix components avoiding embryoid bodies makes this protocol suitable for the use in clinic.-
dc.description.sponsorshipThis work was supported by Wings for Life Foundation, funds for research from the “Miguel Servet” contract of Institute of Health Carlos III of Spanish Ministry of Science and Innovation (CP10/00579) (S.E.), Fund for Health of Spain PI14‐02209 (S.E.), Platform of Biomolecular and Bioinformatics Resources of the Institute of Health Carlos III PT13/0001/0042, Spain (D.L. and S.E.), Czech National Foundation GA CR P304/12/G069 (E.S.), and by the project „BIOCEV “(CZ.1.05/1.1.00/02.0109)” (P.J. and S.E.) and by the European infrastructure for translational medicine (EATRIS‐CZ LM2015064) (E.S.).-
dc.publisherWiley-Blackwell-
dc.publisherAlphaMed Press-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.subjectClinical translation-
dc.subjectCellular therapy-
dc.subjectPluripotent stem cells-
dc.subjectNeural differentiation-
dc.subjectInduced pluripotent stem cells-
dc.subjectEmbryonic stem cells (ESCs)-
dc.subjectDifferentiation-
dc.titleHighly efficient neural conversion of human pluripotent stem cells in adherent and animal-free conditions-
dc.typeartículo-
dc.identifier.doi10.1002/sctm.16-0371-
dc.relation.publisherversionhttps://doi.org/10.1002/sctm.16-0371-
dc.date.updated2018-06-01T13:07:32Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.rights.licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderCzech Science Foundation-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderMinisterio de Ciencia e Innovación (España)-
dc.contributor.funderEuropean Commission-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004837es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.pmid28213969-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.openairetypeartículo-
Aparece en las colecciones: (IBIS) Artículos
(CABIMER) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
animalfree.pdf760,42 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

13
checked on 04-abr-2024

SCOPUSTM   
Citations

26
checked on 15-abr-2024

WEB OF SCIENCETM
Citations

25
checked on 28-feb-2024

Page view(s)

380
checked on 14-abr-2024

Download(s)

341
checked on 14-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons